Clinical trial
Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's…
NCT00134784 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00134784 |
|---|---|
| Title | Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression |
| Official title | [123I]ß-CIT and SPECT in Vivo Three Year Imaging Assessment of Dopamine Transporter Density in Subjects With Early Parkinson's Disease Participating in Earlier vs. Later Levodopa in Parkinson's Disease |
| Acronym | ELLDOPA |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | United States Department of Defense U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | [123I]B-CIT SPECT imaging |
| Enrollment | 142 |
| Start date | Apr 1, 2000 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Aug 25, 2005 |
| Last update posted | Aug 8, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: